Riskpilot← Back to searchSign inGet full accessA&A Investments AB
ABActiveOrg 5591950612Economic activity was not specified by tax authority · NACE 0000Est. 20190 employees
Revenue 2024
SEK 0
EBITDA margin
—
+25% vs 2023
Equity ratio
12.2%
Financial strength
Net profit 2024
SEK 12K
+160% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -25K | +25% |
| Net profit | SEK 12K | +160% |
| Total assets | SEK 513K | +0% |
| Equity | SEK 62K | +23% |
| Employees | 0 | — |
Legal name
A&A Investments AB
Org number
5591950612
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
14 februari 2019
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget har till föremål för sin verksamhet att förvalta aktier i bolag som bedriver apotekverksamhet samt att, direkt eller indirekt, äga och förvalta övrig fast och lös egendom och därmed förenlig verksamhet.
Address
Email
amjed.hussain@apoteksgruppen.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −24 | −34 | −31 | −33 | −25 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −24 | −34 | −31 | −33 | −25 |
| Net financials | −8 | −4 | −5 | −11 | −13 |
| Profit before tax | −32 | −38 | — | −19 | 12 |
| Tax | −0 | −0 | — | — | — |
| Net profit | −32 | −38 | −36 | −19 | 12 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 539 | 513 | 513 | 513 | 513 |
| Equity | 93 | 55 | 69 | 51 | 62 |
| Long-term debt | 427 | 431 | 386 | 396 | 0 |
| Short-term debt | 19 | 27 | 58 | 66 | 451 |
| Total debt | 446 | 458 | 444 | 462 | 451 |
EBITDA margin
-2506600.0%
This company
15.8%
Market median
-15864657% vs market
20202024
Equity ratio
12.2%
This company
38.2%
Market median
-68% vs market
20202024
Return on equity
18.5%
This company
18.4%
Market median
+1% vs market
20202024
Net profit margin
1157200.0%
This company
8.1%
Market median
+14286320% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
7.22×
This company
0.62×
Market median
-1065% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
ME Chief Auditor | Chief Auditor | 2022 |
AH Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2026 | |
| Former (3) | ||
| Deputy Board Member | 2022 – 2024 | |
| Board of Directors | 2022 – 2024 | |
| Deputy Board Member | 2024 – 2026 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
A&A Investments AB 
Apotek Hälsan Sverige ABBoard members of A&A Investments AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Malin Elisabeth Terneblad | Chief Auditor | 0 companies |
| Amjed Hussain | Chief Executive Officer | 0 companies |
| Hussain Abdulwahab Jumaa | Deputy Board Member | 0 companies |
| Ahmed Hussain | Deputy Board Member | 0 companies |
| Ali Abdulwahab Jumaa | Board of Directors | 0 companies |
| Melak Haidar Abdulwahid | Deputy Board Member | 0 companies |